Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Björkander J[au]:

Search results

Items: 1 to 50 of 99

1.

A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases.

Gawel DR, Serra-Musach J, Lilja S, Aagesen J, Arenas A, Asking B, Bengnér M, Björkander J, Biggs S, Ernerudh J, Hjortswang H, Karlsson JE, Köpsen M, Lee EJ, Lentini A, Li X, Magnusson M, Martínez-Enguita D, Matussek A, Nestor CE, Schäfer S, Seifert O, Sonmez C, Stjernman H, Tjärnberg A, Wu S, Åkesson K, Shalek AK, Stenmarker M, Zhang H, Gustafsson M, Benson M.

Genome Med. 2019 Jul 30;11(1):47. doi: 10.1186/s13073-019-0657-3.

2.

Discovering aspects of health-experiences of a web-based health diary among adults with primary immunodeficiency.

Petersson C, Björkander J, Fust R.

Nurs Open. 2018 Jul 10;5(4):642-648. doi: 10.1002/nop2.182. eCollection 2018 Oct.

3.

Fcγ-receptor polymorphisms associated with clinical symptoms in patients with immunoglobulin G subclass deficiency.

Wågström P, Yamada-Fowler N, Dahle C, Nilsdotter-Augustinsson Å, Bengnér M, Söderkvist P, Björkander J.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):853-858. doi: 10.1080/23744235.2018.1510183. Epub 2018 Oct 9.

PMID:
30298768
4.

Intralymphatic allergen immunotherapy against pollen allergy: A 3-year open follow-up study of 10 patients.

Ahlbeck L, Ahlberg E, Nyström U, Björkander J, Jenmalm MC.

Ann Allergy Asthma Immunol. 2018 Nov;121(5):626-627. doi: 10.1016/j.anai.2018.07.010. Epub 2018 Sep 13. No abstract available.

5.

Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.

Nordenfelt P, Nilsson M, Lindfors A, Wahlgren CF, Björkander J.

Allergy Asthma Proc. 2017 Nov 30;38(6):447-455. doi: 10.2500/aap.2017.38.4087. Epub 2017 Aug 30.

PMID:
28855002
6.

Potential Involvement of Type I Interferon Signaling in Immunotherapy in Seasonal Allergic Rhinitis.

Mattson L, Lentini A, Gawel DR, Badam TV, Benson M, Ledin T, Nestor CE, Gustafsson M, Serra-Musach J, Bjorkander J, Xiang Z, Zhang H.

J Immunol Res. 2016;2016:5153184. doi: 10.1155/2016/5153184. Epub 2016 Dec 19.

7.

[Insect venom allergy – the diagnosis can be difficult to make but good treatment is available].

Gülen T, Björkander J.

Lakartidningen. 2016 Aug 4;113. pii: D7CI. Review. Swedish.

8.

Swedish children with hereditary angioedema report good overall health and quality of life despite symptoms.

Nygren A, Nordenfelt P, Lindfors A, Mallbris L, Björkander J, Wahlgren CF.

Acta Paediatr. 2016 May;105(5):529-34. doi: 10.1111/apa.13345. Epub 2016 Feb 23.

PMID:
26821285
9.

A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.

Gustafsson M, Gawel DR, Alfredsson L, Baranzini S, Björkander J, Blomgran R, Hellberg S, Eklund D, Ernerudh J, Kockum I, Konstantinell A, Lahesmaa R, Lentini A, Liljenström HR, Mattson L, Matussek A, Mellergård J, Mendez M, Olsson T, Pujana MA, Rasool O, Serra-Musach J, Stenmarker M, Tripathi S, Viitala M, Wang H, Zhang H, Nestor CE, Benson M.

Sci Transl Med. 2015 Nov 11;7(313):313ra178. doi: 10.1126/scitranslmed.aad2722.

10.

Hereditary Angioedema in Swedish Adults: Report From the National Cohort.

Nordenfelt P, Nilsson M, Björkander J, Mallbris L, Lindfors A, Wahlgren CF.

Acta Derm Venereol. 2016 May;96(4):540-5. doi: 10.2340/00015555-2274.

11.

Does the frequency of respiratory tract infections help to identify humoral immunodeficiencies in a primary health-care cohort?

Wågström P, Bengnér M, Dahle C, Nilsdotter-Augustinsson Å, Neumark T, Brudin L, Björkander J.

Infect Dis (Lond). 2015 Jan;47(1):13-9. doi: 10.3109/00365548.2014.956330. Epub 2014 Nov 7.

PMID:
25378084
12.

Sublingual immunotherapy alters expression of IL-4 and its soluble and membrane-bound receptors.

Nestor CE, Dadfar E, Ernerudh J, Gustafsson M, Björkander J, Benson M, Zhang H.

Allergy. 2014 Nov;69(11):1564-6. doi: 10.1111/all.12505. Epub 2014 Sep 13.

PMID:
25130266
13.

Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.

Nordenfelt P, Dawson S, Wahlgren CF, Lindfors A, Mallbris L, Björkander J.

Allergy Asthma Proc. 2014 Mar-Apr;35(2):185-90. doi: 10.2500/aap.2014.35.3738. Epub 2014 Jan 9.

PMID:
24411585
14.

Comprehensive profiling of peripheral immune cells and subsets in patients with intermittent allergic rhinitis compared to healthy controls and after treatment with glucocorticoids.

Zhang H, Cardell LO, Bjorkander J, Benson M, Wang H.

Inflammation. 2013 Aug;36(4):821-9. doi: 10.1007/s10753-013-9608-0.

PMID:
23413042
15.

[Hereditary angioedema--difficult disease with new therapeutic options].

Björkander J, Bygum A, Nielsen EW.

Lakartidningen. 2012 Jan 18-24;109(3):99-103. Review. Swedish. No abstract available.

PMID:
22448561
16.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Cicardi M, Banerji A, Bracho F, Malbrán A, Rosenkranz B, Riedl M, Bork K, Lumry W, Aberer W, Bier H, Bas M, Greve J, Hoffmann TK, Farkas H, Reshef A, Ritchie B, Yang W, Grabbe J, Kivity S, Kreuz W, Levy RJ, Luger T, Obtulowicz K, Schmid-Grendelmeier P, Bull C, Sitkauskiene B, Smith WB, Toubi E, Werner S, Anné S, Björkander J, Bouillet L, Cillari E, Hurewitz D, Jacobson KW, Katelaris CH, Maurer M, Merk H, Bernstein JA, Feighery C, Floccard B, Gleich G, Hébert J, Kaatz M, Keith P, Kirkpatrick CH, Langton D, Martin L, Pichler C, Resnick D, Wombolt D, Fernández Romero DS, Zanichelli A, Arcoleo F, Knolle J, Kravec I, Dong L, Zimmermann J, Rosen K, Fan WT.

N Engl J Med. 2010 Aug 5;363(6):532-41. doi: 10.1056/NEJMoa0906393. Erratum in: N Engl J Med. 2010 Oct 7;363(15):1486.

17.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.

Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, Stark D, Sur S, Tsai E, Warrington R, Waserman S, Ameratunga R, Bernstein J, Björkander J, Brosz K, Brosz J, Bygum A, Caballero T, Frank M, Fust G, Harmat G, Kanani A, Kreuz W, Levi M, Li H, Martinez-Saguer I, Moldovan D, Nagy I, Nielsen EW, Nordenfelt P, Reshef A, Rusicke E, Smith-Foltz S, Späth P, Varga L, Xiang ZY.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):24. doi: 10.1186/1710-1492-6-24.

18.

HAE international home therapy consensus document.

Longhurst HJ, Farkas H, Craig T, Aygören-Pürsün E, Bethune C, Bjorkander J, Bork K, Bouillet L, Boysen H, Bygum A, Caballero T, Cicardi M, Dempster J, Gompels M, Gooi J, Grigoriadou S, Huffer U, Kreuz W, Levi MM, Long J, Martinez-Saguer I, Raguet M, Reshef A, Bowen T, Zuraw B.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):22. doi: 10.1186/1710-1492-6-22.

19.

Occupational rhinitis caused by tolyltriazole in metalworking fluids.

Graff P, Elmsjö L, Björkander J, Flodin U.

Scand J Work Environ Health. 2008 Oct;34(5):403-4. Epub 2008 Oct 14.

20.

Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B, Fieschi C, Thon V, Abedi MR, Hammarstrom L.

Blood. 2008 Jul 15;112(2):277-86. doi: 10.1182/blood-2007-11-124545. Epub 2008 Mar 4.

PMID:
18319398
21.

The establishment and utility of Sweha-Reg: a Swedish population-based registry to understand hereditary angioedema.

Mallbris L, Nordenfelt P, Björkander J, Lindfors A, Werner S, Wahlgren CF.

BMC Dermatol. 2007 Nov 30;7:6.

22.

Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency.

Pan-Hammarström Q, Salzer U, Du L, Björkander J, Cunningham-Rundles C, Nelson DL, Bacchelli C, Gaspar HB, Offer S, Behrens TW, Grimbacher B, Hammarström L.

Nat Genet. 2007 Apr;39(4):429-30. No abstract available.

23.

Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up.

Olinder-Nielsen AM, Granert C, Forsberg P, Friman V, Vietorisz A, Björkander J.

Scand J Infect Dis. 2007;39(1):44-50.

PMID:
17366012
24.

Production of interleukin-12 by monocytes and interferon-gamma by natural killer cells in allergic patients during rush immunotherapy.

Plewako H, Wosińska K, Arvidsson M, Björkander J, Håkansson L, Rak S.

Ann Allergy Asthma Immunol. 2006 Oct;97(4):464-8.

PMID:
17069100
25.

Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy.

Plewako H, Wosińska K, Arvidsson M, Bjorkander J, Skov PS, Håkansson L, Rak S.

Int Arch Allergy Immunol. 2006;141(4):346-53. Epub 2006 Aug 29.

PMID:
16940746
26.

Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.

Björkander J, Nikoskelainen J, Leibl H, Lanbeck P, Wallvik J, Lumio JT, Braconier JH, Pavlova BG, Birthistle K, Engl W, Walter S, Ehrlich HJ.

Vox Sang. 2006 May;90(4):286-93.

PMID:
16635071
27.

Antibody response to the Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in healthy and infection-prone individuals with IgG3 subclass deficiency.

Hahn-Zoric M, Ulanova M, Friman V, Björkander J, Oxelius VA, Lucas A, Hanson LA.

J Clin Immunol. 2004 Sep;24(5):561-70.

PMID:
15359115
28.
29.

Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study.

Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, Bjorkander J, Olsen JH.

Clin Exp Immunol. 2002 Dec;130(3):495-500.

30.

Clinical and molecular analysis of patients with defects in micro heavy chain gene.

Lopez Granados E, Porpiglia AS, Hogan MB, Matamoros N, Krasovec S, Pignata C, Smith CI, Hammarstrom L, Bjorkander J, Belohradsky BH, Casariego GF, Garcia Rodriguez MC, Conley ME.

J Clin Invest. 2002 Oct;110(7):1029-35.

31.

European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries.

Quinti I, Pierdominici M, Marziali M, Giovannetti A, Donnanno S, Chapel H, Bjorkander J, Aiuti F; European Study Group for the Surveillance of Immunoglobulin Safety.

Clin Immunol. 2002 Sep;104(3):231-6.

PMID:
12217332
32.

Lack of IgA in C(mu)-deficient patients.

Pan Q, Matamoros N, Björkander J, Conley ME, Hammarström L.

Nat Immunol. 2002 Jul;3(7):595; author reply 596. No abstract available.

PMID:
12087410
33.

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.

Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J.

J Clin Immunol. 2000 Mar;20(2):94-100.

PMID:
10821460
34.

Ischaemic heart disease in primary immunodeficiency.

Hammar N, Linnersjö A, Hansson GK, Björkander J, Hammarström L.

Lancet. 1998 Nov 28;352(9142):1786. No abstract available.

PMID:
9848383
35.

Variable increases of IgG and IgM antibodies in milk of IgA deficient women.

Hahn-Zoric M, Carlsson B, Björkander J, Mellander L, Friman V, Padyukov L, Hanson LA.

Pediatr Allergy Immunol. 1997 Aug;8(3):127-33.

PMID:
9532252
36.

Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience.

Björkander J, Fasth A, Widell A.

Clin Ther. 1996;18 Suppl B:73-82.

PMID:
8930444
37.

Family and linkage study of selective IgA deficiency and common variable immunodeficiency.

Vorechovský I, Zetterquist H, Paganelli R, Koskinen S, Webster AD, Björkander J, Smith CI, Hammarström L.

Clin Immunol Immunopathol. 1995 Nov;77(2):185-92.

PMID:
7586726
38.

Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy.

Gardulf A, Björvell H, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Nyström T, Søeberg B, et al.

J Adv Nurs. 1995 May;21(5):917-27.

PMID:
7541407
39.

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.

Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G, et al.

Lancet. 1995 Feb 11;345(8946):365-9.

PMID:
7845120
40.

Linkage of IgA deficiency to Gm allotypes; the influence of Gm allotypes on IgA-IgG subclass deficiency.

Oxelius VA, Carlsson AM, Hammarström L, Björkander J, Hanson LA.

Clin Exp Immunol. 1995 Feb;99(2):211-5.

41.

Aberrations in titer and avidity of serum IgM and IgG antibodies to microbial and food antigens in IgA deficiency.

Cardinale F, Friman V, Carlsson B, Björkander J, Armenio L, Hanson LA.

Adv Exp Med Biol. 1995;371B:713-6. No abstract available.

PMID:
7502882
42.

Hepatitis C virus transmission by intravenous immunoglobulin.

Yap PL, McOmish F, Webster AD, Hammarstrom L, Smith CI, Bjorkander J, Ochs HD, Fischer SH, Quinti I, Simmonds P.

J Hepatol. 1994 Sep;21(3):455-60.

PMID:
7836718
43.
44.

Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination.

Friman V, Quiding M, Czerkinsky C, Nordström I, Larsson L, Ericson D, Björkander J, Theman K, Kilander A, Holmgren J, et al.

Clin Exp Immunol. 1994 Feb;95(2):222-6.

45.

Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases.

Lindberg C, Persson LI, Björkander J, Oldfors A.

Acta Neurol Scand. 1994 Feb;89(2):123-31.

PMID:
8191875
46.

B-cell activation in duodenal mucosa after oral cholera vaccination in IgA deficient subjects with or without IgG subclass deficiency.

Nilssen DE, Friman V, Theman K, Björkander J, Kilander A, Holmgren J, Hanson LA, Brandtzaeg P.

Scand J Immunol. 1993 Aug;38(2):201-8.

PMID:
8346420
47.

Molecular diagnosis of X-linked agammaglobulinaemia.

Vorechovsky I, Zhou JN, Vetrie D, Bentley D, Björkander J, Hammarström L, Smith CI.

Lancet. 1993 May 1;341(8853):1153. No abstract available. Erratum in: Lancet.. Vorechkovsky, I [corrected to Vorechovsky, I]. Lancet. 2003 Apr 19;361(9366):1394.

PMID:
8097835
48.

Periodontal disease and dental caries in relation to primary IgG subclass and other humoral immunodeficiencies.

Dahlén G, Björkander J, Gahnberg L, Slots J, Hanson LA.

J Clin Periodontol. 1993 Jan;20(1):7-13.

PMID:
8421120
49.

Intestinal immunoglobulin production after oral cholera vaccination in patients with IgA deficiency with or without IgG subclass deficiency.

Nilssen DE, Friman V, Theman K, Björkander J, Kilander A, Holmgren J, Hanson LA, Brandtzaeg P.

Immunodeficiency. 1993;4(1-4):55-7. No abstract available.

PMID:
8167734
50.

Supplemental Content

Loading ...
Support Center